Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties.

Seth NP, Xu R, DuPrie M, Choudhury A, Sihapong S, Tyler S, Meador J, Avery W, Cochran E, Daly T, Brown J, Rutitzky L, Markowitz L, Kumar S, Beavers T, Bhattacharya S, Chen H, Parge V, Price K, Wang Y, Sukumaran S, Pao Y, Abouzahr K, Elwood F, Duffner J, Roy S, Narayanaswami P, Hubbard JJ, Ling LE

Injectable myocardium-derived hydrogels with SDF-1α releasing for cardiac repair.

Xu J, Brown J, Shaik R, Soto-Garcia L, Liao J, Nguyen K, Zhang G, Hong Y

Multi-Omics Approach Reveals Genes and Pathways Affected in Miller-Dieker Syndrome.

Mahendran G, Breger K, McCown PJ, Hulewicz JP, Bhandari T, Addepalli B, Brown JA

The Relationship Between Point-of-Care Tool Use and Nurses' Self-Efficacy.

Knowles AL, Neal P, Pell C, Bloom L, Brown J

Changing public perceptions of alcohol, alcohol harms and alcohol policies: A multi-methods study to develop novel framing approaches.

Fitzgerald N, Angus K, Howell R, Labhart H, Morris J, Fenton L, Woodrow N, Castellina M, Oldham M, Garnett C, Holmes J, Brown J, O'Donnell R

Trends and patterns of dual use of combustible tobacco and e-cigarettes among adults in England: A population study, 2016-2024.

Jackson SE, Cox S, Shahab L, Brown J

Australian general practitioners' knowledge, attitudes and prescribing intentions for e-cigarettes as a smoking cessation aid: a nationwide baseline and 12-month follow up survey.

Selamoglu M, Malamardi S, Erbas B, Wilson H, Brown J, Barton C

Trends in smoking prevalence and socio-economic inequalities across regions in England: A population study, 2006 to 2024.

Jackson SE, Cox S, Buss V, Tattan-Birch H, Brown J

Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

Davids MS, Ryan CE, Lampson BL, Ren Y, Tyekucheva S, Fernandes SM, Crombie JL, Kim AI, Weinstock M, Montegaard J, Walker HA, Greenman C, Patterson V, Jacobson CA, LaCasce AS, Armand P, Fisher DC, Lo S, Olszewski AJ, Arnason JE, Ahn IE, Brown JR

Human MeCP2 binds to promoters and inhibits transcription in an unmethylated yeast genome.

Brown JAR, Ling MYM, Ausió J, Howe LJ